GCPNX | JEPCX | GCPNX / JEPCX | |
Total Expense Ratio | 0.63 | 1.35 | 47% |
Annual Report Gross Expense Ratio | 1.05 | 1.35 | 78% |
Fund Existence | 8 years | 7 years | - |
Gain YTD | -0.342 | 0.283 | -121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 260M | 6.3B | 4% |
Annual Yield % from dividends | 0.75 | 7.50 | 10% |
Returns for 1 year | 6.88 | 6.78 | 101% |
Returns for 3 years | 42.79 | 32.71 | 131% |
Returns for 5 years | 69.63 | 65.73 | 106% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBTIX | 29.15 | -0.19 | -0.65% |
Fidelity Advisor Biotechnology I | |||
MSBWX | 11.77 | -0.16 | -1.34% |
Morgan Stanley American Resilience C | |||
CCQYX | 14.74 | -0.23 | -1.54% |
Columbia Disciplined Core Inst3 | |||
EXHAX | 25.70 | -0.41 | -1.57% |
Manning & Napier Pro-Blend Max Term S | |||
GINUX | 26.52 | -0.54 | -2.00% |
Goldman Sachs Small Cap Gr Insghts R6 |